{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:53:00Z","timestamp":1790484780074,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T00:00:00Z","timestamp":1395792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cult Med Psychiatry"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11013-014-9370-2","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T17:16:19Z","timestamp":1395767779000},"page":"217-236","source":"Crossref","is-referenced-by-count":25,"title":["The Earlier the Better: Alzheimer\u2019s Prevention, Early Detection, and the Quest for Pharmacological Interventions"],"prefix":"10.1007","volume":"38","author":[{"given":"Annette","family":"Leibing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,26]]},"reference":[{"key":"9370_CR1","unstructured":"ADI (Alzheimer\u2019s Disease International) 2013 About dementia, www.alz.co.uk\/about-dementia , accessed October 2013."},{"key":"9370_CR2","unstructured":"AllBusiness 2007 Early Detection Push, http:\/\/www.allbusiness.com\/insurance\/health-insurance-government-health-medicare\/6622991-1.html , accessed April 2011."},{"key":"9370_CR3","unstructured":"Alzheimer\u2019s Association 2013 New Diagnostic Criteria, http:\/\/www.alz.org\/research\/diagnostic_criteria\/ , accessed October 2013."},{"key":"9370_CR4","unstructured":"American Heart Association 2013 New heart disease and stroke prevention guidelines released, http:\/\/blog.heart.org\/new-heart-disease-and-stroke-prevention-guidelines-released\/ , accessed November 2013."},{"key":"9370_CR5","volume-title":"The Truth about Drug Companies: How They Deceive us and What to do About it","author":"M. Angells","year":"2004","unstructured":"Angells, M. - The Truth about Drug Companies: How They Deceive us and what to do about it. New York: Random House, 2004."},{"key":"9370_CR6","doi-asserted-by":"crossref","unstructured":"Applbaum, K. 2009 Is Marketing the Enemy of Pharmaceutical Innovation? Hastings Center Report 39(4): 13\u201317, 2009.","DOI":"10.1353\/hcr.0.0157"},{"key":"9370_CR7","unstructured":"Applbaum, K. 2012 see three articles on the pharmaceutical industry, http:\/\/somatosphere.net\/author\/kalman-applbaum ."},{"key":"9370_CR113","doi-asserted-by":"crossref","unstructured":"Applby, B.S., et al. 2013 A review: Treatment of Alzheimer\u2019s Disease Discovered in Repurposed Agents. Dementia and Geriatric Cognitive Disorders 35(1\u20132): 1\u201322.","DOI":"10.1159\/000345791"},{"issue":"2","key":"9370_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1620\/tjem.179.65","volume":"179","author":"H. Arai","year":"1996","unstructured":"Arai, H. (1996) Biological markers for the clinical diagnosis of Alzheimer\u2019s disease (abstract).Tohoku J Exp Med. 179(2): 65\u201379.","journal-title":"The Tohoku Journal of Experimental Medicine"},{"issue":"1","key":"9370_CR9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1741-7015-11-246","volume":"11","author":"J.H. Barnett","year":"2013","unstructured":"Barnett, J.H., Hachinski, V., and A.D. Blackwell (2013) Cognitive health begins at conception: Adressing dementia as a lifelong and preventable condition. BMC Med. 11(1): 246.","journal-title":"BMC Medicine"},{"key":"9370_CR107","doi-asserted-by":"crossref","unstructured":"Battistin, L., and A. Cagnin 2010 Vascular Cognitive Disorder. A Biological and Clinical Overview. Neurochemical Research 35(12): 1933\u20131938.","DOI":"10.1007\/s11064-010-0346-5"},{"issue":"3","key":"9370_CR10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1467-9566.2009.01198.x","volume":"32","author":"K. Bell","year":"2010","unstructured":"Bell, K. (2010) Cancer Survivorship, Mor(t)ality and Lifestyle Discourses on Cancer Prevention, Sociology of Health and Illness 32(3): 349-364","journal-title":"Sociology of Health and Illness"},{"issue":"3","key":"9370_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0197-4580(98)00052-9","volume":"19","author":"N.C. Berchtold","year":"1998","unstructured":"Berchtold, N.C. and C.W. Cotman 1998 Evolution in the conceptualization of dementia and Alzheimer\u2019s disease: Greco-Roman period to the 1960s. Neurobiology of Aging 19(3): 173-189","journal-title":"Neurobiology of Aging"},{"key":"9370_CR12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/gps.930050603","volume":"5","author":"G.E. Berrios","year":"1990","unstructured":"Berrios G.E. - Alzheimer\u2019s disease: a conceptual history. International Journal of Geriatric Psychiatry 5: 355-365, 1990.","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"9370_CR13","volume-title":"Global Pharmaceuticals: Ethics, Markets, Practices","author":"J. Biehl","year":"2006","unstructured":"Biehl, J. - Pharmaceutical Governance. In A. Petryna, A. Lakoff, and A. Kleinman (eds.), Global Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke University Press, 2006."},{"key":"9370_CR14","doi-asserted-by":"crossref","unstructured":"Birks, J. 2005 Cholinesterase Inhibitors for Alzheimer\u2019s disease. Cochrane Database of Systematic Reviews 2006. doi: 10.1002\/14651858.CD005593 .","DOI":"10.1002\/14651858.CD005593"},{"key":"9370_CR15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","volume":"114","author":"G. Blessed","year":"1968","unstructured":"Blessed G., Tomlinson B.E., Roth M 1968. The association between quantitative measures of dementia and senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: 797\u2013811.","journal-title":"The British Journal of Psychiatry"},{"issue":"4","key":"9370_CR16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cger.2013.07.009","volume":"29","author":"N.L. Campbell","year":"2013","unstructured":"Campbell NL et al 2013 Risk Factors for the Progression of Mild Cognitive Impairment to Dementia. Clinical Geriatric Medicine 29(4): 873-893.","journal-title":"Clinics in Geriatric Medicine"},{"issue":"2","key":"9370_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jalz.2012.12.004","volume":"9","author":"M.C. Carrillo","year":"2013","unstructured":"Carrillo, M.C. et al. \u2013 Can we prevent Alzheimer\u2019s disease? Secondary \u201cprevention\u201d trials in Alzheimer\u2019s disease. Alzheimers Dement. 9(2): 123-131, 2013.","journal-title":"Alzheimers Dement"},{"key":"9370_CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nicl.2013.02.006","volume":"2","author":"G. Ch\u00e9telat","year":"2013","unstructured":"Ch\u00e9telat, G. et al. 2013 Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer\u2019s disease. Neuroimage Clin. 2: 356-365.","journal-title":"Neuroimage Clinical"},{"key":"9370_CR19","unstructured":"Consumer Reports 2013 Evaluating Prescription Drugs Used to Treat: Alzheimer\u2019s Disease; Comparing Effectiveness, Safety, and Price, http:\/\/www.consumerreports.org\/health\/resources\/pdf\/best-buy-drugs\/AlzheimersFINAL.pdf , accessed October 2013."},{"key":"9370_CR20","volume-title":"Biographies of Scientific Objects","year":"2000","unstructured":"Daston, L. (ed.) - Biographies of Scientific Objects. Chicago: University of Chicago Press, 2000."},{"issue":"3","key":"9370_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1474-4422(13)70030-9","volume":"12","author":"T. Dehnel","year":"2013","unstructured":"Dehnel, T. \u2013 The European Dementia Prevention Initiative. Lancet Neurology 12(3): 227-228, 2013.","journal-title":"Lancet Neurology"},{"issue":"8","key":"9370_CR22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B. Dubois","year":"2007","unstructured":"Dubois B. et al. - Research Criteria for the Diagnosis of Alzheimer\u2019s Disease. Lancet Neurol. 6(8): 734-46, 2007.","journal-title":"The Lancet Neurology"},{"issue":"11","key":"9370_CR23","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B. Dubois","year":"2010","unstructured":"Dubois, B. et al. - Revising the Definition of Alzheimer\u2019s Disease: A New Lexicon. Lancet Neurol. 9(11): 1118-27, 2010.","journal-title":"The Lancet Neurology"},{"issue":"6","key":"9370_CR24","first-page":"446","volume":"26","author":"D. Ermini-F\u00fcnfschilling","year":"1993","unstructured":"Ermini-F\u00fcnfschilling D, St\u00e4helin HB 1993 Is Prevention of Dementia Possible (article in German). Zeitschrift f\u00fcr Gerontologie 26(6): 446-452.","journal-title":"Zeitschrift f\u00fcr Gerontologie"},{"key":"9370_CR25","unstructured":"Fagan, T., and G. Strobel 2013 Background Text, http:\/\/www.alzforum.org\/res\/for\/journal\/detail.asp?liveID=192 , accessed August 2013."},{"issue":"6","key":"9370_CR26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2389.2003.51260.x","volume":"51","author":"H. Feldman","year":"2003","unstructured":"Feldman, H et al. - Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer\u2019sdisease and the effect on caregiver burden.J Am Geriatr Soc.51(6):737-44, 2003.","journal-title":"The Journal of the American Geriatrics Society"},{"issue":"4","key":"9370_CR27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.amjcard.2010.03.077","volume":"106","author":"E.A. Ferenczi","year":"2010","unstructured":"Ferenczi, E.A. et al. - Can a Statin Neutralize the Cardiovascular Risk of Unhealthy Dietary Choices? The American Journal of Cardiology 106(4): 587-592, 2010.","journal-title":"The American Journal of Cardiology"},{"key":"9370_CR28","unstructured":"Friedland, R.P. 2001 Should Dietary Modifications be Recommended to Lower the Risk of Alzheimer\u2019s Disease? In 53rd Annual Meeting, American Academy of Neurology, Philadelphia, May 6, 2001."},{"key":"9370_CR29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jalz.2011.03.006","volume":"7","author":"S. Gauthier","year":"2011","unstructured":"Gauthier, S. et al. - Commentary on \u201cRecommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease.\u201d A Canadian Perspective, Alzheimer\u2019s & Dementia 7: 330\u2013332, 2011.","journal-title":"A Canadian Perspective, Alzheimer\u2019s & Dementia"},{"key":"9370_CR30","first-page":"193","volume":"38","author":"N. Gellerstedt","year":"1933","unstructured":"Gellerstedt, N. \u2013 ZurKenntnis der Hirnver\u00e4nderungenbei der normalenAltersinvolution. UpsalaL\u00e4karef\u00f6reningsF\u00f6rhandlingar 38: 193-408,1933. And JAMA 103(2): 131, 1934.","journal-title":"Upsala L\u00e4karef\u00f6renings F\u00f6rhandlingar"},{"key":"9370_CR100","doi-asserted-by":"crossref","unstructured":"Granovetter, M. 1985 Economic Action and Social Structure: The Problem of Embeddedness. American Journal of Sociology 91(November): 481\u2013510.","DOI":"10.1086\/228311"},{"key":"9370_CR31","doi-asserted-by":"crossref","DOI":"10.1353\/book.3313","volume-title":"Prescribing by Numbers: Drugs and the Definition of Disease","author":"J.A. Greene","year":"2007","unstructured":"Greene JA 2007 Prescribing by Numbers: Drugs and the Definition of Disease. Baltimore, MD: Johns Hopkins University Press."},{"key":"9370_CR32","unstructured":"Harvard Mental Health Letter 2004 Alzheimer\u2019s Drugs: Are They Worth it? November issue. http:\/\/www.health.harvard.edu , accessed March 2009."},{"key":"9370_CR33","doi-asserted-by":"crossref","DOI":"10.1525\/9780520951815","volume-title":"Pharmageddon","author":"D. Healy","year":"2012","unstructured":"Healy, D 2012 Pharmageddon. Berkeley: University of California Press"},{"key":"9370_CR34","unstructured":"Johnson and Johnson 2010 http:\/\/www.jnj.com\/connect\/news\/all\/janssen-pharmaceutica-nv-announces-collaboration-to-develop-diagnostic-biosignatures-for-pre-symptomatic-identification-of-alzheimers-disease , accessed April 2011."},{"key":"9370_CR35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T. Jonsson","year":"2012","unstructured":"Jonsson, T et al. \u2013 A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96-99, August 2012.","journal-title":"Nature"},{"issue":"suppl 2","key":"9370_CR36","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1111\/j.1753-4887.2010.00352.x","volume":"68","author":"R.N. Kalaria","year":"2010","unstructured":"Kalaria, R.N. - Vascular Basis for Brain Degeneration: Faltering Controls and Risk Factors for Dementia. Nutr. Review 68 (suppl 2): S74-87, 2010.","journal-title":"Nutrition Review"},{"key":"9370_CR37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1976.00500040001001","volume":"33","author":"R. Katzman","year":"1976","unstructured":"Katzman, R. - The prevalence and malignancy of Alzheimer disease. A major killer. Archives of Neurology 33: 217\u2013218, 1976.","journal-title":"Archives of Neurology"},{"issue":"1","key":"9370_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0890-4065(00)80013-4","volume":"14","author":"S.H. Kaufman","year":"2000","unstructured":"Kaufman, S.H. 2000 Senescence, decline, and the quest for a good death: Contemporary dilemmas and historical antecedents. J Aging Studies 14(1): 1-23","journal-title":"Journal of Aging Studies"},{"issue":"3","key":"9370_CR39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jalz.2011.04.003","volume":"7","author":"Z.S. Khachaturian","year":"2011","unstructured":"Khachaturian ZS 2011 Revised criteria for diagnosis of Alzheimer\u2019s disease: National Institute on Aging-Alzheimer\u2019s Association diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia 7(3): 253\u2013256","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"9370_CR114","unstructured":"Kolata, G. 2013 Experts Reshape Treatment Guide for Cholesterol. The New York Times, November 12, 2013. http:\/\/www.nytimes.com\/2013\/11\/13\/health\/new-guidelines-redefine-use-of-statins.html?_r=0 ."},{"key":"9370_CR40","volume-title":"Psychiatrie. Ein Lehrbuch f\u00fcr Studierende und \u00c4rzte","author":"E. Kraepelin","year":"1910","unstructured":"Kraepelin, E. 1910 Psychiatrie. Ein Lehrbuch f\u00fcr Studierende und \u00c4rzte (2nd edn). Leipzig: Barth Verlag.","edition":"2"},{"key":"9370_CR41","first-page":"257","volume":"86","author":"V.A. Kral","year":"1962","unstructured":"Kral, V.A. - Senescent Forgetfulness: Benign and Malignant. Can Med Assoc J 86: 257\u2013260, 1962.","journal-title":"Canadian Medical Association Journal"},{"key":"9370_CR42","first-page":"247","volume-title":"Biographies of Scientific Objects","author":"B. Latour","year":"2000","unstructured":"Latour, B. - On the Partial Existence of Existing and Nonexisting Objects. in: Daston, L. (ed.) Biographies of Scientific Objects. Chicago: The University of Chicago Press, pp. 247-269, 2000."},{"key":"9370_CR104","doi-asserted-by":"crossref","unstructured":"Leibing, A. 2006 Divided Gazes: Alzheimer\u2019s Disease, the Person Within, and Death in Life. In Thinking About Dementia\u2014Culture, Loss, and the Anthropology of Senility. A. Leibing and L. Cohen, eds., pp. 240\u2013268. New Brunswick, NJ: Rutgers University Press.","DOI":"10.2307\/j.ctt5hjbhp.15"},{"issue":"1","key":"9370_CR43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1363461509102297","volume":"46","author":"A. Leibing","year":"2009","unstructured":"Leibing, A. - Tense prescriptions? Alzheimer medications and the anthropology of uncertainty. Transcultural Psychiatry 46(1): 180-206, 2009a.","journal-title":"Transcultural Psychiatry"},{"key":"9370_CR44","unstructured":"Leibing, A. 2009b From the Periphery to the Center: Treating Noncognitive, Especially Behavioral and Psychological, Symptoms of Dementia. In Do We Have a Pill for That? Treating Dementia. J. Ballenger, P. Whitehouse, C. Lyketsos, P. Rabins, and J. Karlawish, eds., pp. 74\u201397. Baltimore: The Johns Hopkins University Press."},{"key":"9370_CR46","unstructured":"Leibing, A. 2014 The Earlier the Better\u2014Alzheimer\u2019s Prevention, Early Detection, and the Quest for Pharmacological Interventions. Invited Conference: Colloque \u201cResponsible Innovation in a Multiple World\u2014The Case of Alzheimer Diagnostics\u201d, 20\u201321 February 2014. Holland: University of Twente."},{"issue":"4","key":"9370_CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1357034X13477163","volume":"19","author":"A. Leibing","year":"2013","unstructured":"Leibing, A. and A. Kampf 2013 Neither body nor brain: Comparing attitudes to prostate cancer and Alzheimer\u2019s disease. Body & Society 19(4): 61-91.","journal-title":"Body & Society"},{"key":"9370_CR48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1745-6215-13-68","volume":"13","author":"E.L. LeMoyne","year":"2012","unstructured":"LeMoyne, EL, Curnier, D, St-Jacques, S, and D Ellemberg - The effects of exercise during pregnancy on the newborn\u2019s brain: study protocol for a randomized controlled trial. Trials 13: 68, 2012.","journal-title":"Trials"},{"key":"9370_CR49","volume-title":"Defying Dementia, Understanding and Preventing Alzheimer\u2019s and Related Disorders","author":"R.A. Levine","year":"2010","unstructured":"Levine, R.A. - Defying Dementia, Understanding and Preventing Alzheimer\u2019s and Related Disorders. Lanham: Rowman and Littlfield, 2010."},{"key":"9370_CR50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.300.6732.1121","volume":"300","author":"R. Levy","year":"1990","unstructured":"Levy, R. \u2013 Are drugs targeted at Alzheimer\u2019s disease useful? BMJ 300: 1121-1132, 1990.","journal-title":"BMJ"},{"key":"9370_CR102","doi-asserted-by":"crossref","unstructured":"Lieberman, J.A., et al. 2005 Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine 353(12): 1209\u20131223.","DOI":"10.1056\/NEJMoa051688"},{"issue":"27","key":"9370_CR51","doi-asserted-by":"crossref","first-page":"23024","DOI":"10.1074\/jbc.M112.367011","volume":"287","author":"M. Maesako","year":"2012","unstructured":"Maesako, M et al - Exercise is more effective than diet control in preventing high fat diet-induced \u03b2-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J Biol Chem. 287(27): 23024-23033, 2012.","journal-title":"The Journal of Biological Chemistry"},{"key":"9370_CR52","unstructured":"Mcilroy, A. 2010 New Tools Allow for Early Detection of Alzheimer\u2019s,\u2019 Globe and Mail September 22, http:\/\/www.theglobeandmail.com\/life\/health\/dementia\/new-tools-allow-for-early-detection-of-alzheimers-but-theres-a-catch\/article1717718\/ , accessed February 2010."},{"issue":"3","key":"9370_CR53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.0887-378X.2004.00319.x","volume":"82","author":"M.J. Mehlman","year":"2004","unstructured":"Mehlman, M.J. 2004 Cognition-Enhancing Drugs. Milbank Q. 82(3): 483\u2013506","journal-title":"Milbank Quarterly"},{"key":"9370_CR103","doi-asserted-by":"crossref","unstructured":"Mount, C., and C. Downton 2006 Alzheimer\u2019s Disease: Progress or Profit? Nature Medicine 12(7): 780\u2013784.","DOI":"10.1038\/nm0706-780"},{"key":"9370_CR71","unstructured":"No Author 2013 How Science Goes Wrong, October 19th\u201325th. The Economist 26\u201330."},{"issue":"3","key":"9370_CR54","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/j.jalz.2012.01.014","volume":"9","author":"A.H. Noel-Storr","year":"2013","unstructured":"Noel-Storr AH, Flicker L, Ritchie CW, Nguyen GH et al. - Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia. Alzheimer\u2019s & Dementia 9(3): e96-e105, 2013.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"9370_CR55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1363461509102291","volume":"46","author":"M. Oldani","year":"2009","unstructured":"Oldani, M. (2009). Uncanny scripts: Understanding Pharmaceutical Emplotment in the Aboriginal Context. Transcultural Psychiatry 46(1): 131-156.","journal-title":"Transcultural Psychiatry"},{"key":"9370_CR56","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.280.23.2001","volume":"280","author":"D. Ornish","year":"1998","unstructured":"Ornish, D, Scherwitz, LW, Billings, JH, Gould, KL, Merritt, TA, et al. \u2013 Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280: 2001\u20132007, 1998.","journal-title":"JAMA"},{"key":"9370_CR110","doi-asserted-by":"crossref","unstructured":"Pedersen, N. 2010 Reaching the Limits of Genome-Wide Significance in Alzheimer Disease. JAMA 303: 1864\u20131865.","DOI":"10.1001\/jama.2010.609"},{"key":"9370_CR111","doi-asserted-by":"crossref","unstructured":"Petersen, R.C. 2004 Mild Cognitive Impairment as a Diagnostic Entity. Journal of Internal Medicine 52(3): 183\u2013194.","DOI":"10.1111\/j.1365-2796.2004.01388.x"},{"key":"9370_CR116","doi-asserted-by":"crossref","unstructured":"Petryna, A. 2006 Globalizing Human Subjects Research. In Global Pharmaceuticals, Ethics, Markets, Practices. A. Petryne, A. Lakoff, and A. Kleinman, eds., pp. 33\u201360. Durham, NC: Duke University Press.","DOI":"10.1215\/9780822387916-002"},{"key":"9370_CR112","unstructured":"Pfizer 2010 http:\/\/www.pfizer.ca\/en\/media_centre\/news_releases\/article?year=2010&article=339 , accessed April 2011."},{"key":"9370_CR57","unstructured":"Rabin, R.C. 2010 Good\u2019 Cholesterol May Lower Alzheimer\u2019s Risk. New York Times, (Dec 16), http:\/\/well.blogs.nytimes.com\/2010\/12\/16\/good-cholesterol-may-lower-alzheimers-risk\/?emc=eta1 , accessed December 2010."},{"key":"9370_CR58","unstructured":"Ranii, D. 2011 Chapel Hill Firm to Lead Alzheimer\u2019s Trials. NewsObserver, www.newsobserver.com\/2011 , August 23, 2011."},{"key":"9370_CR106","doi-asserted-by":"crossref","unstructured":"Rapoport, M., and B.H. Mulsant 2010 Pathway to Prevention: Great Progress has been Made But We are not yet There. International Psychogeriatrics 22: 1193\u20131195.","DOI":"10.1017\/S1041610210001882"},{"key":"9370_CR118","unstructured":"Rocca, W.A. 1994 Frequency, Distribution, and Risk Factors for Alzheimer's Disease. Nursing Clinics of North America 29(1): 101\u2013111."},{"issue":"19","key":"9370_CR59","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","volume":"80","author":"C.M. Roe","year":"2013","unstructured":"Roe C.M., et al. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5\u00a0years later.Neurology 80(19):1784-1791, 2013.","journal-title":"Neurology"},{"issue":"3","key":"9370_CR60","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JAD-2006-9S340","volume":"9","author":"A.D. Roses","year":"2006","unstructured":"Roses, A.D. - On the Discovery of the Genetic Association of Apolipoprotein E Genotypes and Common Late-onset Alzheimer Disease. Journal of Alzheimers Dis. 9(3): 361-366, 2006.","journal-title":"Journal of Alzheimers Disease"},{"issue":"1","key":"9370_CR61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1532-5415.2005.53029.x","volume":"53","author":"D.R. Royall","year":"2005","unstructured":"Royall, D. R. - The emperor has no clothes: Dementia treatment on the eve of the aging era. Journal of the American Geriatric Society 53(1): 163\u2013164, 2005.","journal-title":"Journal of the American Geriatric Society"},{"key":"9370_CR62","unstructured":"Russ, T.C., and J.R. Morling 2012 Anti-dementia drugs for people with memory problems but without dementia (Cochrane study), http:\/\/summaries.cochrane.org\/CD009132\/anti-dementia-drugs-for-people-with-memory-problems-but-without-dementia , accessed April 2013."},{"key":"9370_CR63","doi-asserted-by":"crossref","first-page":"a011460","DOI":"10.1101\/cshperspect.a011460","volume":"2","author":"D. Selkoe","year":"2012","unstructured":"Selkoe D, Mandelkow E and D Hotzman \u2013 Deciphering Alzheimer Disease. Cold Spring Harb Perspect Med 2:a011460, 2012.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"9370_CR64","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.socscimed.2008.01.010","volume":"66","author":"S. Sismondo","year":"2008","unstructured":"Sismondo, S. 2008 How Pharmaceutical Industry Funding Affects Trial Outcomes: Causal Structures and Responses. Social Science & Medicine 66: 1909-1914.","journal-title":"Social Science & Medicine"},{"key":"9370_CR108","doi-asserted-by":"crossref","unstructured":"Slooter, A.J., et al. 1997 Apolipoprotein E epsilon4 and the Risk of Dementia with Stroke. A Population-Based Investigation. JAMA 277(10): 818\u2013821.","DOI":"10.1001\/jama.1997.03540340052032"},{"issue":"4","key":"9370_CR65","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jaging.2011.03.002","volume":"25","author":"A. Smith","year":"2011","unstructured":"Smith, A., Kobayashi, K., Chappell, N. and D. Hoxsey- The controversial promises of cholinesterase inhibitors for Alzheimer\u2019s disease and related dementias: A qualitative study of caregivers\u2019 experiences.Journal of Aging Studies 25(4):397-406, 2011.","journal-title":"Journal of Aging Studies"},{"key":"9370_CR66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000295660","volume":"7","author":"D.L. Sparks","year":"2010","unstructured":"Sparks DL et al. 2010 Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment. Neurodegenerative Disease 7: 183\u2013186.","journal-title":"Neurodegenerative Disease"},{"issue":"3","key":"9370_CR67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"R.A. Sperling","year":"2011","unstructured":"Sperling, R.A. et al. - Toward Defining the Preclinical Stages of Alzheimer\u2019s Disease. Alzheimer\u2019s & Dementia 7(3): 280-292, 2011.","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"9370_CR68","first-page":"4","volume":"11","author":"R.A. Sperling","year":"2012","unstructured":"Sperling, RA and KA Johnson 2012 Dementia: New Criteria but no New Treatments. JAMA 11: 4-5.","journal-title":"JAMA"},{"key":"9370_CR69","volume-title":"Decoding Darkness, The Search for the Genetic Causes of Alzheimer\u2019s Disease","author":"R.E. Tanzi","year":"2000","unstructured":"Tanzi, RE and AB Parsson 2000 Decoding Darkness, The Search for the Genetic Causes of Alzheimer\u2019s Disease. Cambridge, MA: Perseus"},{"issue":"3","key":"9370_CR70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","volume":"291","author":"P.N. Tariot","year":"2004","unstructured":"Tariot, PN et al. (for the Memantine Study Group) \u2013 Memantine treatment in patients with moderate to severe Alzheimer Disease already receiving donepezil. JAMA 291(3): 317-324, 2004.","journal-title":"JAMA"},{"key":"9370_CR72","doi-asserted-by":"crossref","unstructured":"The Lancet 2011 Editorial: Lessons from Lipitor. doi: 10.1016\/S0140-6736(11)61858-8 .","DOI":"10.1016\/S0140-6736(11)61858-8"},{"key":"9370_CR73","unstructured":"Thomas, K. 2013 Questions for a New Class of Cholesterol Drugs. The New York Times, November 14, 2013, \u2018Business day\u2019 section."},{"key":"9370_CR74","doi-asserted-by":"crossref","unstructured":"Timmermann, C. 2011 Appropriating Risk Factors: The Reception of An American Approach to Chronic Disease in the Two Generations, ca. 1950\u20131990. Social History Medicine. doi: 10.1093\/Shm\/hkr051 .","DOI":"10.1093\/shm\/hkr051"},{"key":"9370_CR105","doi-asserted-by":"crossref","unstructured":"Trinh, N.H., J. Hoblyn, S. Mohanty, and K. Yaffe 2003 Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric Symptoms and Functional Impairment in Alzheimer Disease: A Meta-analysis. Journal of the American Medical Association 289(2): 210\u2013216.","DOI":"10.1001\/jama.289.2.210"},{"key":"9370_CR117","doi-asserted-by":"crossref","unstructured":"Van Dujn, C.M., et al. 1994 Interaction Between Genetic and Environmental Risk Factors for Alzheimer's Disease: A Reanalysis of Case-control Studies. EURODEM Risk Factors Research Group. Genetic Epidemiology 11(6): 539\u2013551","DOI":"10.1002\/gepi.1370110609"},{"key":"9370_CR101","unstructured":"Van Melick, E.J. 2004 Atypical Antipsychotics in the Elderly. Tijdschrift Voor Gerontologie En Geriatrie 35(6): 240\u2013245."},{"key":"9370_CR75","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jalz.2011.10.008","volume":"8","author":"P.J. Visser","year":"2012","unstructured":"Visser, PJ, Vos, S, van Rossum, I. and P. Scheltens 2012 Comparison of International Working Group criteria and National Institute on Aging\u2013Alzheimer\u2019s Association criteria for Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia 8: 560\u2013563.","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"9370_CR76","volume-title":"The Myth of Alzheimer\u2019s: What You Aren\u2019t Being Told About Today\u2019s Most Dreaded Diagnosis","author":"P. Whitehouse","year":"2008","unstructured":"Whitehouse, P. and D. George 2008 The Myth of Alzheimer\u2019s: What You Aren\u2019t Being Told About Today\u2019s Most Dreaded Diagnosis. New York: St. Martins Press."},{"key":"9370_CR77","unstructured":"Wilson, D. 2010 Risks Seen in Cholesterol Drug Use in Healthy People. New York Times, March 30, online issue."},{"key":"9370_CR115","doi-asserted-by":"crossref","unstructured":"Wirth, M. 2013 Associations between Alzheimer Disease Biomarkers, Neurodegeneration, and Cognition in Cognitively Normal Older People. JAMA Neurology 70(12): 1512\u20131519.","DOI":"10.1001\/jamaneurol.2013.4013"},{"key":"9370_CR109","doi-asserted-by":"crossref","unstructured":"Yamamura, T., et al. 1984 New Mutants of Apolipoprotein E Associated with Atherosclerotic Diseases but not to Type III Hyperlipoproteinemia. Journal of Clinical Investigation 74(4): 1229\u20131237.","DOI":"10.1172\/JCI111532"}],"container-title":["Culture, Medicine, and Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11013-014-9370-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11013-014-9370-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11013-014-9370-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T13:58:52Z","timestamp":1689083932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11013-014-9370-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,26]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["9370"],"URL":"https:\/\/doi.org\/10.1007\/s11013-014-9370-2","relation":{},"ISSN":["0165-005X","1573-076X"],"issn-type":[{"value":"0165-005X","type":"print"},{"value":"1573-076X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,26]]}}}